IL10 and neoplasm: IL-10 mediates tumor immunosuppression and leads to the negative prognosis of tumor-bearing hosts [7–8], whose underlying mechanisms are that IL-10 could inhibit T cell proliferation and induce T cell to differentiate to the regulatory T cell phenotype [9].